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Pesticide exposure during brain development could represent an important risk factor for the onset of
neurodegenerative diseases. Previous studies investigated the effect of permethrin (PERM) administered
at 34mg/kg, a dose close to the no observable adverse effect level (NOAEL) from post natal day (PND)
6 to PND 21 in rats. Despite the PERM dose did not elicited overt signs of toxicity (i.e. normal body
weight gain curve), it was able to induce striatal neurodegeneration (dopamine and Nurr1 reduction, and
lipid peroxidation increase). The present study was designed to characterize the cognitive deﬁcits in the
current animal model. When during late adulthood PERM treated rats were tested for spatial working
memory performances in a T-maze-rewarded alternation task they took longer to choose for the correct
arm in comparison to age matched controls. No differences between groups were found in anxiety-like
state, locomotor activity, feeding behavior and spatial orientation task. Our ﬁndings showing a selective
effect of PERM treatment on the T-maze task point to an involvement of frontal cortico-striatal circuitry
rather than to a role for the hippocampus. The predominant disturbances concern the dopamine (DA)
depletion in the striatum and, the serotonin (5-HT) and noradrenaline (NE) unbalance together with a
hypometabolic state in the medial prefrontal cortex area. In the hippocampus, an increase of NE and a
decrease of DA were observed in PERM treated rats as compared to controls. The concentration of the
most representative marker for pyrethroid exposure (3-phenoxybenzoic acid) measured in the urine of
rodents 12h after the last treatment was 41.50g/L and it was completely eliminated after 96h.onoamines. Introduction
Pyrethroids are among the most frequently used pesticides
orldwide. They are used in agriculture, public health, and homes,
s well as for the protection of textiles, such as carpets. Because
hese insecticides are relatively nonvolatile, the primary source
f exposure is believed to be through diet. Additional exposure
ia ingestion of contaminated household dust may occur after the
ndoor application of pesticides such as permethrin that is themain
yrethroid used in the home for indoor pest control, in pet sham-
oos and treatment for wood furniture.
Population-based biomonitoring data for pyrethroid metabo-
ites measured in US and German population revealed that
yrethroid insecticide exposure is widespread. The presence of its
etabolites in the urine of U.S. and German residents indicates
hat children may have higher exposures than adolescents andadults (Barr et al., 2010; Heudorf and Angerer, 2001). A developing
brain is much more susceptible to the toxic effects of chemi-
cals than an adult brain. This vulnerability period extends from
fetal development through infancy, childhood and adolescence.
The biological effects of pyrethroid are in part caused by their
ability to alter neuronal activity since they interact with speciﬁc
binding sites of voltage-gated sodium channel (VGSC) slowing
the rate of VGSC closing, prolonging the inward sodium conduc-
tance and then shifting themembrane tomore polarized potentials
(Narahashi, 1996). A secondary consequence to cell membrane
depolarization is an increased Ca+2 inﬂux into the neurons through
voltage-gated calcium channel (VGCC) that contributes to impact
neuronal synaptic plasticity of neurons (Imamura et al., 2006).
These changes in synaptic transmission may alter neuronal func-
tion and may contribute to excitotoxicity and neurodegenerative
pathology (Gomez-Villafuertes et al., 2007).Studies conducted in our laboratory demonstrated that PERM
exposure, at a dose of 34mg/kg close to the NOAEL (25mg/kg)
during early life, induced, later in the life of rats, a signiﬁcant neu-
rodegeneration of the striatum (Str) characterized by a decrease of
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Burr1 gene and protein expression, and an increased lipid perox-
dation (Carloni et al., 2012). Lower DA levels and accelerated DA
urnover following early life PERM treatment was also observed
Nasuti et al., 2007). Nurr1 is a transcription factor belonging to
he nuclear receptor family and it regulates the development and
aintenance of dopaminergic neurons. In fact, our previous stud-
es demonstrated that early life permethrin treatment impaired the
urr1 expression and then the dopaminergic system.
To further explore the impact of early life PERM exposure, in
he present study, we sought to investigate cognitive functions
elated to spatial working memory in pre-senescent rats that were
xposed to this insecticide during the neonatal period. Concomi-
antly with spatial working memory tasks, DA, NE, 5-HT and their
ajor metabolites levels from different brain areas were also mea-
ured ex vivo.
. Materials and methods
.1. Materials
All reagents were of pure analytical grade. Technical grade (75:25,
rans:cis; 94% purity) 3-phenoxybenzyl-(1R,S)-cis,trans-3-(2,2-dichlorovinyl)-2,2-
imethylcyclopropanecarboxyl-ate, PERM (NRDC 143) were generously donated by
r. A. Stefanini of ACTIVA (Milan, Italy). Corn oil, dopamine, 3,4-dihydroxy phenyl-
cetic acid (DOPAC), 3-methoxy-4-hydroxyphenylacetic acid (HVA), dihydroxyben-
ylamine (DHBA), 1-octanesulphonic acid sodium salt, sodium metabisulphite and
cetonitrile were obtained from Sigma (Milan, Italy).
.2. Animals
Male and female Wistar rats from Charles River (Calco, LC, Italy), weighing
50–270g and about 90 days old were housed in plastic (Makrolon) cages (ﬁve rats
er cage) in a temperature controlled room (21±5 ◦C) and 60% humidity on 12h
ight/dark inverted cycle (lights on at 7:00p.m.) and maintained on a laboratory
iet with water ad libitum. Rat pups born in our laboratory from primiparous dams
ere used in the study. The parturition day was set as PND0. On PND1, all litters
ere examined externally for the presence of gross abnormalities, sexed, weighed,
he female pupswere discarded and twomale pupswere assigned to each damuntil
eaning (PND21) for this study. No cross-fostering was employed. At 2 days of age,
itters were randomly assigned to two experimental groups (n=11 pups for each).
ats were weighed at 4-week intervals throughout the course of study.
At PND21, six treated and 6 control rats were housed for 4 days in metabolic
ages and submitted to 3-phenoxybenzoic acid measurement in the urine.
On pre-senescent age (PND500), control and PERM treated rats (n=7 per group)
ere subjected to a battery of behavioral tests comprising the T-maze test, water
aze spatial reference memory task, open ﬁeld (OF) test and elevated plus-maze.
ome cage food intake of pre-senescent rats was also measured. In a subsequent
xperiment, 3 control and 3 PERM treated rats were trained on the T-maze task
or three days. On day four, at completion of the T-maze experiment, rats were
acriﬁced, brains were removed and the medial prefrontal cortex (mPFC), the
ippocampus (Hip) and the Str were dissected out for biochemical analysis. All pro-
edures were conducted in adherence to the European Community Council Directive
or Care and Use of Laboratory Animals.
.3. Treatment
PERM was dissolved in corn oil and administered by gavage at the dose of
4.05mg/kg/4ml, which corresponds to 1/50 of LD50 as determined in adult rats
Cantalamessa, 1993). PERM or its vehicle (corn oil, 4ml/kg) was administered once
day from PND6 to PND21. PERM dose was adjusted daily based on rat pups body
eight. On PND21, the offspring were weaned and the littermates were housed
ogether. For the experiments, the experimental groups were formed by drawing
nimals from different litters, so that no group contained siblings.
.4. Urine 3-phenoxybenzoic acid levels
3-Phenoxybenzoic acid (3-PBA) is the main metabolite of the PERM and other
yrethroids resulting from the oxidation of the 3-phenoxybenzyl alcohol. Its con-
entration in the urine is the most representative marker for pyrethroid exposure
n rodents (Nakamura et al., 2007) and humans (Leng et al., 1997).
To assess PERM levels, after the last treatment day (PND 21), 6 control and 6
ERM treated rats were housed in metabolic cages for 4 days. Every 12h, the urine
amples were collected and the volumes were measured. Urines were immediately
rozen at −20 ◦C until assayswere performed. Immediately prior to analytical detec-
ion, a hydrolysis step was introduced to convert potentially conjugated 3-PBA into
ree 3-PBA. The 2-PBA was added to urine samples and used as an internal standard.
rieﬂy, urine samples were pre-treated with KOH and then, by solid-phase extrac-tion using Strata X C cartridge, the 3- and the 2-PBA were isolated. Derivatization
of 3-PBA and 2-PBA was achieved by addition of DIC and HFIP. At this point, 1L of
upper layer was injected on a Thermo Trace-Ultra gas chromatograph coupled to an
ion trap mass detector Thermo Polaris, operated in the electron impact ionization at
70eV. The ion source temperature and the MS transfer temperature were at 250 ◦C.
Operating in the splitless mode, helium was used as carrier gas at a constant ﬂow
rate of 1.3mL/min. The injector was maintained at 240 ◦C. Final values of 3-PBA at
12, 24, 48, 72 and 96h were expressed as g/L and then multiplied for the corre-
sponding urine volume so that the quantity of 3-PBA per each urine sample was
obtained.
2.5. T-maze apparatus
Spatial non-matching-to-place testing was conducted on an enclosed-T maze
made of clear plexiglas T-shaped platform with a start arm (70 cm long and 11 cm
wide) and two identical goal arms (51 cm long and 11 cm wide), all arms were bor-
dered with 11-cm-high walls. At the distal end of each arm a barrier (3 cm high)
concealed a food well to contain the food reward (0.1 g pellet). A small grid com-
partment containing inaccessible fresh food was located at the end of both arms to
mask the food odor (coming from the well) to prevent the use of olfactory cues to
locate the food. Apparatus arms were wiped with 10% alcohol solution and dried
with a paper towel between trials to eliminate the use of local odor cues. The room
was surrounded by extramaze spatial cues and was illuminated by a dim light to
reduce rat anxiety.
2.6. T-maze testing
The T-maze test is classically used for spatial working memory studies in the
rat. In the T maze, rats are trained to choose between two goal arms alternatively
rewardedwith foodand the rat is trained to visit the rewardedarm toobtain it. Daily,
training session is composed of several choice trials. Animals’ behavior is scored for
accuracy (% correct arm choice), perseveration (number of consecutive incorrect
trials) and choice reaction time (CRT) for each trial.
In the present study, one group of control (N=7) and one group of PERM (N=7)
treated ratswere used. Oneweek prior to the beginning of the experiment, ratswere
housed in individual cages and mildly food deprived (85% of their voluntary daily
food intake). T-maze training started by moving the animals into the testing room
where they were kept for 10min prior to initiate the performance. Animals were
then positioned on the maze where they had free access to food in both arms for
10min a day for 2 consecutive days. Starting from day 3, rats were subjected to 11
daily consecutive choice trials. In the ﬁrst daily trial, both goal arms were rewarded
and the rat was asked to choose one of the two arms. In the second trial, only the
arm opposite to the ﬁrst choice was baited. The test continued for other 9 daily
trials in which the two goal arms were rewarded with an alternated sequence. At
the beginning of each trial, the rat was placed on the start arm of the T make where
it was conﬁned with a wood block for 5 s. The block was then removed and the
animal allowed to run toward the two goal arms and to choose one of them. After
the choice, the rat was conﬁned in the goal arm (using a wood block) and allowed to
eat the food until ﬁnished. Rats were subjected this training for 7 consecutive days
(10 choice trials per day) for a total of 70 trials.
The experiment was replicated in a new group of rats (N=6). Speciﬁcally, 3 con-
trols and3PERMtreatedanimalswere subjected to the sameexperimental sequence
described above but the choice tests were stopped on day 4 when, immediately
after completion of the behavioral task, the rats were sacriﬁced and the brains were
removed for neurochemical analysis. Day 4 was when the maximal difference in the
T maze performance between controls and PERM treated rats was observed.
2.7. Morris Water maze testing
One day after completion of the T-maze testing, controls (N=7) and PERM
(N=7) treated rats were trained in the hidden-platform water maze task. The maze
consisted of a large, circular tank (diameter 150 cm; wall height 60 cm) ﬁlled with
water (23–25 ◦C) and placed in the center of a large room with extramaze cues. An
escape platform was located 1 cm beneath the water surface in a ﬁxed position and
a nontoxic black paint was added to obscure the platform and to aid tracking of the
animals’ swim paths. In order to secure them from the water, the rats had to ﬁnd
a hidden escape platform located in the same position across all days of training.
Animal performance was tracked by video camera using EthoVision 7.0 software
(Noldus Information Technology, The Netherlands). Brieﬂy, rats received four trials
per day for ﬁve consecutive days using a 30 sec intertrial interval. On each training
trial, ratswere placed in thewater and allowed to swimuntil ﬁnding the platformor
for 90 s at which time they were placed on the platform by the experimenter. Once
on the platform, rats were allowed stay for 30 s to acquire memory of its position
using the surrounding cues. The start position for each trial was semi-randomly var-
ied among four equally spaced positions around the perimeter of the pool. Latency
to escapeplatformwas thedependentmeasure,with shorter latency time indicating
betterperformance.Meanproximity toescapeplatformwas recordedas theprimary
measure of the animals’ cognitive ability based ondemonstration of its superior sen-
sitivity compared to alternative measures (Gallagher et al., 1993). Lower scores, on
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excreted at 12h and 24h following the last PERM administration
was 0.11±0.01 and 0.01±0.004g, respectively. The 3-PBA was
completely eliminated after 96h (Fig. 1).he proximity to escape platform, indicate a more accurate search because of short
istance of rat to the platform during the trial.
.8. Locomotor activity
One day after completion of the water maze task, controls (N=7) and PERM
N=7) treated rats were tested for their locomotor behavior using automated loco-
otoractivityboxes (MedAssociates,VT05478)aspreviously reported (Nasuti et al.,
008). Locomotor activity was recorded for 10min, starting 1min after placing the
nimal in the test cage. Each rat was automatically recorded by interruptions of two
rthogonal light beams (3.5 cm and 13.0 cm above the activity box ﬂoor), which
ere connected to automatic software (Activity Monitor, Med Associates). The
ehavioral parameters observed were ambulatory (number of horizontal episodes),
earing (number of vertical episodes), and stereotype counts (number of grooming
ovements). The OF was divided into two squares and, ambulatory, rearing and
tereotype counts into the central area (25 cm×25 cm) which can be considered
n unprotected area for rats, were also recorded. These parameters are expressed
s percentage of total ambulatory, rearing and stereotype counts, respectively. Low
ercentage of activities in the center area indicates a higher anxiety-like state.
.9. Elevated plus maze
One day after completion of the locomotor activity test, controls (N=7) and
ERM (N=7) treated ratswere evaluated in the elevated plusmaze (EPM) to analyze
heir anxiety-like behavior. After completion of the locomotor activity testing, the
nxiety-like behavior of rats was assessed by a cross shaped wood made elevated
aze, consisting of two opposite open arms 50 cm×10 cm, and two opposite arms
nclosed by 40 cm high walls with two open arms and two closed arms. The maze
as elevated 50 cm from the ﬂoor and lit by dim light. A closed-circuit TV camera
as mounted vertically over the maze, and the numbers of entries and time spent
n enclosed and open arms were tracked by EthoVision software. Changes in the
ercentage of time spent and number of entries into the open arms indicate changes
n anxiety-like behavior (Pellow et al., 1985). A greater number of entries and time
pent in open arms means less anxiety-like condition.
.10. Food intake measurement
Daily home cage food intake of control (N=7) and PERM (N=7) treated ratswere
easured during one week. Food consumption was monitored the week after the
ast behavioral test took place.
.11. Monoamines and metabolites measurements in Str, Hip and mPFC
On day 4 of the T-maze training, at completion of the task, controls (N=3) and
ERM (N=3) treated rats were killed by CO2, brains were rapidly removed, and the
ip, the Str and themPFCwere dissected as described by Spijker (2011) according to
he rat brain atlas coordinates (Paxinos and Watson, 2007). Speciﬁcally, the mPFC
as hand-dissected from the coronal slice ∼2.5–4.5mm anterior to bregma and
ncluded the prelimbic cortex, part of the infralimbic and cingulate cortices. The two
alves of the Str (dorsal and ventral) and of the Hip were separately hand-dissected
ut. The two halves of Hipwas hand-dissected from the slice ∼3.5–5.5mmposterior
o bregma and included dentate gyrus and CA1-3 hippocampal regions. Tissue was
tored at −70 ◦C until used for monoamine, glucose and lactate analysis.
Levels of catecholamines (DA, DOPAC, HVA, NE) were analyzed with a Waters
00 controller pump, a Rheodyne 7295 injector with a 10L loop, and an Antec Ley-
enDecade II detector (the operatingpotentialwas 0.75V). Separationwas achieved
n aWaters Symmetry RP-C18 column (4.6mm×150mm, 5m). Themobile phase
onsisted of 0.045Mmonobasic sodiumphosphate, 0.001M1-octanesulphonic acid
odium salt, 0.006% triethylamine, 0.015% 100MsodiumEDTA and 6% acetonitrile.
he pH of the mobile phase was adjusted to 3.0 by o-phosphoric acid. The mobile
hase was ﬁltered and degassed by vacuum. A ﬂow rate of 1mL/min was used in
ll experiments (Cannazza et al., 2005). The separation of 5-HT and its metabolite,
-HIAA, were carried out with the ﬂow-rate set at 1.20mL/min and the detector
otential set at +780mV vs. Ag/AgCl reference electrode. For the mobile phase,
uffer 6.90 g of NaH2PO4·H2O (50mM), 37mg of Na2EDTA (0.1mM) and 702mg
f 1-octanesulfonic acid sodium salt monohydrate (2.3mM) were dissolved in UHQ
ater. After the pH was lowered to 3.0 with phosphoric acid, the ﬁnal volume was
djusted to 1 L with UHQ water. A total of 790mL of the buffer was then mixed with
10mL of acetonitrile. The chromatographic separation of the main metabolite of
E, MHPG, was achieved with the ﬂow-rate set at 1.20mL/min and the detector
otential was +800mV vs. Ag/AgCl reference electrode. The mobile phase was a
ixture of 5% of methanol and 95% of an aqueous solution of 10.5 g/L citric acid,
0mg/L EDTA and 20mg/L OSA buffered at pH 3.5 with 1mol/L NaOH. The ﬂow rate
as 1mL/min. Each compound was identiﬁed on the basis of retention time and
he concentration was established from the peak area ratio using DHBA as inter-
al standard. Final values were expressed in terms of nanogram per gram of tissue.
easurements were performed in triplicate for each original sample.2.12. Glucose and lactate levels in Str, Hip and mPFC
In the CNS, glucose is metabolized by astrocytes to produce lactate that is then
released from astrocytes and utilized by neurons as energy source (Tsacapoulos and
Magistretti, 1996; Pellerin, 2003). A correct balance between glucose (low level) and
lactate (high level) reveals a correct energy metabolism of neurons. On the contrary,
an insufﬁcient lactate production indicates poor metabolic neuronal function and
reduced protection against insult (Uehara et al., 2012; Wyss et al., 2011; Newman
et al., 2011).
Hence, to monitor neuronal metabolism, glucose and lactate levels in the Str,
Hip and mPFC were measured.
According to the method of Bleiberg et al. (1991), a reversed-phase high-
performance liquid chromatography (RP-HPLC) separation method with UV
detection was developed for the detection of lactate and glucose. All analyses were
carried out on a Waters 600 controller pump, a Rheodyne 7295 injector with a
10L loop, equipped with a Waters 2996 photodiode array detector. The chro-
matographic analysis of lactate was carried out with a Symmetry RP-C18 column
(4.6mm×150mm, 5m); the mobile phase was a phosphoric acid solution (pH
2.5) with 5% acetonitrile. The ﬂow rate was 1.0mL/min; the lactate was detected at
210nm. The detection of glucose was carried out on a Supelcosil LC-NH2 column
(4.6mm×250mm, 5m); the mobile phase was a mixture of 75% of acetonitrile
and 25% of water and UV was set at 190nm. The ﬂow rate was 2.0mL/min. Final
values were expressed as nanogram per gram of tissue.
2.13. Statistical analysis
For the T-maze and the Morris water maze tests, a two-way ANOVA with one
factor within (time) and one factor between (treatment) was employed. The EPM,
the OF and the food intake tests were analyzed by mean of a one-way (treatment)
ANOVA. Monoamine, glucose and lactate levels in the different brain areas were
evaluated separately with nonparametric Mann-Whitney-U test. When appropri-
ate post-hoc analysis was carried out using the Newman–Keuls test. Statistical
signiﬁcance was set at P<0.05.
3. Results
3.1. Effect of PERM on body weight
Rats treated with vehicle or PERM did not show gross signs
of abnormalities throughout the experimental period. During the
course of the 500 days of observation, no signiﬁcant group dif-
ferences (F[1,12] =4.37, P>0.05) in body weight were observed. A
signiﬁcant time effect indicated that the growth rate was similar in
both groups (F[16,192] =253, P<0.01).
3.2. Urine 3-phenoxybenzoic acid levels
Results showed that, in rats treatedwith PERM, 90%of the 3-PBA
was excretedwithin the ﬁrst 24h. Speciﬁcally, the amount of 3-PBAFig. 1. 3-PBA urinary levelmeasured 12, 24, 48, 72 and 96h after the rats are treated
per o.s.: subchronically from PND6 to PND21 with permethrin (34mg/kg/4ml). All
data are expressed as mean± SEM for six rats.
Fig. 2. Effects of early life PERM treatment on T-maze task in pre-senescent rats.
(A) % correct responses, (B) choice reaction time and (C) numbers of incorrect arm
choices made in consecutive trials during six days of testing (10 trials/day). All data
a
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lower levels (P<0.05) of DOPAC and DA were observed in PERM
T
E
tre expressed as mean± SEM. Group sizes: control (N=7), PERM (N=7).
.3. Effect of PERM on spatial working memory in the T-maze task
ANOVA did not reveal signiﬁcant main effects of PERM treat-
ent (F[1,12] =4.12, P=0.065) nor treatment× time interaction
F[5,60] =0.32, P>0.05), whereas a signiﬁcant effect of time
F[5,60] =3.41, P<0.01) was observed (Fig. 2A).
able 1
ffects of early life PERM treatment on locomotor activities of pre-senescent rats. Ambula
he center zone of the open ﬁeld task (% Amb. Cnts, % Rear. Cnts) in 10min. All data are ex
Group Amb. Cnts Rear. Cnts
Control 2031.24 ± 151.99 94.57 ± 4
PERM 1820.14 ± 337.19 96.57 ± 1On the other hand, when CRT responses were analyzed
(Fig. 2B), ANOVA revealed a signiﬁcant main effect of treat-
ment (F[1,138] =8.48, P<0.01) and day (F[5,690] =12.49, P<0.001),
but not a signiﬁcant treatment×day interaction (F[5,690] =0.59,
P>0.05). Post hoc Newman–Keuls test demonstrated that CRT was
signiﬁcantly longer in the PERM treated group compared with that
of the controls (P<0.01).
The last dependent variable analyzed was the number of incor-
rect arm choices made in consecutive trials (Fig. 2C). ANOVA
failed to reveal a signiﬁcant main effect of treatment (F[1,12] =3.2,
P>0.05) and treatment×day interaction (F[5,60] =0.17, P>0.05).
3.4. Effect of PERM on spatial reference memory in the Morris
water maze
In animals trained to search a hidden-platform in a ﬁxed
location, ANOVA revealed no signiﬁcant treatment differ-
ences (F[1,54] =1.54, P>0.05) and treatment×day interaction
(F[4,216] =0.3, P>0.05) on escape latencies. A signiﬁcant time
effect (F[4,216] =70.82, P<0.01) indicated that the rate of task
acquisition was similar in both groups. When proximity to escape
platform was analyzed by ANOVA, results revealed no signiﬁcant
effect of treatment (F[1,54] =0.99, P>0.05) and treatment×day
interaction (F[4,216] =0.3, P>0.05). A signiﬁcant effect of time on
proximity to escape platform (F[4,216] =73.48, P<0.01) indicated
similar rate of task acquisition in both groups.
3.5. Effect of PERM on locomotor activities in the OF
As shown in Table 1, in the OF test, ANOVA revealed no differ-
ences in the horizontal (F[1,12] =0.32, P>0.05) and in the vertical
(F[1,12] =0.01, P>0.05) activities in the two groups of rats. ANOVA,
also revealed absence of differences in locomotor activity (% ambu-
latory counts: F[1,12] =0.66, P>0.05;% vertical counts: F[1,12] =0.03,
P>0.05) occurring in the central area of the OF.
3.6. Effect of PERM on anxiety-like behavior in the EPM
ANOVA computed on the % open arm entries (F[1,12] =0.00973,
P>0.05) and on the % time spent in the open arms
(F[1,12] =0.00973, P>0.05) revealed no signiﬁcant group dif-
ferences, reﬂecting the same level of anxiety-like responses in
PERM treated rats and in controls.
3.7. Effect of PERM on food consumption
ANOVA revealed no difference between PERM treated rats and
controls in food intake (F[1,12] =0.750, P>0.05) neither a treat-
ment×day interaction (F[6; 72] =0.38, P>0.05) was observed.
3.8. Effect of PERM on monoamines and their metabolites levels
in Str, Hip and mPFC areas
As shown in Table 2, in the Str and in the Hip, a signiﬁcanttreated rats as compared to controls. Conversely, in the Str and
Hip, the levels of HVA, a DA metabolite, were signiﬁcantly higher
(P<0.05) in the PERM treated rats than in the controls. In addition,
tory and rearing counts (Amb. Cnts, Rear. Cnts) and their respective percentage in
pressed as mean± SEM. Group sizes: control (N=7), PERM (N=7).
% Amb. Cnts % Rear. Cnts
.65 4.84 ± 0.78 1.20 ± 0.46
9.11 6.45 ± 1.81 1.04 ± 0.73
Table 2
Regional dopamine (DA), norepinephrine (NE), and serotonin (5-HT) contents and their metabolites in the striatum, mPFC and hippocampus areas of pre-senescent control
and PERM treated rats (N=3 per group). Data represent the mean± SEM. Measurements were performed in triplicate for each sample. The arrows show signiﬁcant increase
or decrease compared to the control group.
Monoamines and metabolites Treatment Striatum (ng/mg tissue) PFC (ng/mg tissue) Hippocampus (ng/mg tissue)
l-DOPA Control 0.173±7.0×10−4 0.029±5.0×10−4 0.065±6.0×10−4
PERM 0.103±4.0×10−4*↓ 0.033±4.8×10−3 0.035±4.0×10−4*↓
DA Control 5.025±4.6×10−3 0.326±2.4×10−3 0.181±3.0×10−4
PERM 0.512±7.0×10−4*↓ 0.324±2.1×10−3 0.094±6.0×10−4*↓
DOPAC Control 0.582±2.6×10−3 0.039±2.0×10−4 0.035±4.0×10−4
PERM 0.184±4.3×10−3*↓ 0.038±1.2×10−3 0.036±1.7×10−3
HVA Control 0.062±8.0×10−4 0.006±1.0×10−4 0.007±2.0×10−4
PERM 0.079±4.0×10−4*↑ 0.006±1.0×10−4 0.011±1.0×10−4*↑
NE Control 0.028±2.0×10−4 0.002±2.0×10−4 0.046±3.0×10−4
PERM 0.078±4.0×10−4*↑ 0.016±2.0×10−4*↑ 0.065±3.0×10−4*↑
MHPG Control 0.057±8.0×10−4 0.049±5.0×10−4 0.051±1.0×10−3
PERM 0.042±1.1×10−3*↓ 0.042±7.0×10−4*↓ 0.029±6.0×10−4*↓
5-HT Control 1.152±8.4×10−3 4.123±4.8×10−3 0.402±3.9×10−3
PERM 1.182±7.4×10−3 1.774±2.4×10−2*↓ 0.388±1.2×10−2
5-HIAA Control 0.006±1.0×10−4 0.016±1.0×10−4 0.006±1.0×10−4
PERM 0.006±1.0×10−4 0.023±7.0×10−4*↑ 0.006±2.0×10−4
Turnover ratios Treatment Striatum (ng/mg tissue) PFC (ng/mg tissue) Hippocampus (ng/mg tissue)
DOPAC/DA Control 0.116±6.0×10−4 0.120±4.0×10−4 0.198±2.2×10−3
PERM 0.361±8.9×10−3*↑ 0.118±3.8×10−3 0.388±1.5×10−2*↑
HVA/DA Control 0.012±1.0×10−4 0.019±2.0×10−4 0.037±1.2×10−3
PERM 0.154±9.0×10−4*↑ 0.020±5.0×10−4 0.120±1.0×10−3*↑
MHPG/NE Control 2.065±4.6×10−2 28.44±3.5 1.111±2.8×10−2
PERM 0.540±1.4×10−2*↓ 2.591±6.1×10−2*↓ 0.441±7.1×10−3*↓
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which hydrolyze the pyrethroids only in the serum of rats. This
would be of signiﬁcant concern to human health as decreased
metabolismof pyrethroids in humans could lead to increased expo-5-HIAA/5-HT Control 0.005±1.0×1
PERM 0.005±1.0×1
* P<0.05 vs. control.
he turnover ratios of DOPAC/DA and HVA/DA for the PERM treated
roup were much higher than that of the control group both in
he Str (DOPAC/DA=3 times; HVA/DA=12 times) and in the Hip
DOPAC/DA=2 times; HVA/DA=3 times).
A signiﬁcant increase of NE levels in the Str, Hip and mPFC was
bserved in PERM treated rats as compared to controls (P<0.05).
onversely, the levels of MHPG, a NE metabolite, were signiﬁcantly
P<0.05) reduced in Str, Hip and mPFC of PERM treated rats. The
HPG/NE turnover ratios of the PERM treated group, in the Str, Hip
nd mPFC, were 4, 11 and 2.5 times lower (P<0.05) than that of the
ontrol group.
In the mPFC, a signiﬁcant (P<0.05) decrease of 5-HT and a
igniﬁcant (P<0.05) increase of 5-HIAA, its metabolite, were also
bserved. In the mPFC, the turnover ratio of 5-HIAA/5-HT in the
ERM treated group was 3 times higher (P<0.05) than in the con-
rols.
Overall, these ﬁndings indicate that PERM treatment elicited
substantial reduction in DA and 5-HT levels and elevation
n dopaminergic and serotonergic turnover. Conversely, follow-
ng PERM treatment, NE levels were increased and its turnover
ecreased.
.9. Effect of PERM on glucose and lactate levels in the Str, Hip
nd mPFC
As shown in Fig. 3, a signiﬁcantly higher glucose (P<0.05) and
ower lactate (P<0.05) concentrations were observed in the mPFC
f PERM treated rats compared to controls. In particular, PERM
reated rats hadhigher glucose (P<0.05) and lower lactate (P<0.05)
evels compared with the control rats.0.004±2.7×10 0.014±2.0×10
0.013±4.0×10−4*↑ 0.015±7.0×10−4
4. Discussion
Pyrethroid compounds are present at low concentrations in the
environment and in human tissue. They are increasingly used as
pesticides and theirwidespread presence is a cause of growing tox-
icological concerns. The pyrethroids are primarily metabolized in
the liver of mammals by cytochrome P450 oxidation, or esterase
hydrolysis followed by the formation of glucuronide and glycine
conjugates. Common metabolites, such as the 3-PBA, are found in
the urine of both laboratory animals andhumans. However, there is
a signiﬁcant species differences in the metabolism of pyrethroids:
carboxylesterases have been identiﬁed as the family of esteraseFig. 3. Regional glucose and lactate levels measured in striatum, hippocampus
and mPFC of pre-senescent control and PERM treated rats. Data represent the
mean± SEM for three rats. Group sizes: control (N=3), PERM (N=3). Measurements
were performed in triplicate for each sample. *P<0.05 vs. control group.
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wure at the target tissue and increased potency (Godin et al., 2007).
n addition, pyrethroids are highly lipophilic and by easily crossing
he blood–brain-barrier they can reach the CNS at concentrations
hat canbepotentiallyneurotoxic.Detrimental effects onCNScould
e particularly pronounced if, as shown in our previous studies,
xposure to these agents occurs in early life (from PND6 to PND21)
hen the rat brain is in a highly active neurodevelopmental phase
s synaptogenesis. The choice to treat rats in the period derives
rom evidences reporting that exposure to pesticide in this period
f life corresponds to the third trimester of pregnancy in human
nd it has been associated with the development of various dis-
ases in adult and old age (Clancy et al., 2007; Vaiserman, 2011;
arker, 2001). For this reason we sought to determine the conse-
uence of neonatal PERM exposure on late adulthood neurological
unctions.
Results revealed that PERM exposure from PND6 to PND21 did
ot elicited overt signs of toxicity in the rat. Animals showed a
ormal body weight gain curve and a normal feeding behavior.
owever, when during late adulthood PERM treated rats were
ested for working memory performances, a memory form largely
rocessed by themPFC, in a T-maze-rewarded alternation task they
ook longer to choose for the correct arm in comparison to age
atched controls. The PERM treated rats showed a clear trend to
higher number of consecutive incorrect arm choice. The differ-
nce fromcontrolwasparticularly evident during theﬁrst fourdays
f training. A non-signiﬁcant trend to difference in the percent of
orrect response was also observed.
In subsequent experiments neither differences in EPM anxiety-
ike responses nor in OF locomotor activitywere observed between
ERMand control rats. Daily food intake and bodyweightwere also
dentical in the two groups of animals. Altogether, these ﬁndings
ule out the possibility that, in the T-maze, the different response
etween PERM and vehicle treated rats could depend upon dif-
erences in anxiety-like state, in locomotor activity or in feeding
ehavior. Most notably, however, it was found that in the water
aze spatial orientation task, a type of memory that is mostly
rocessed in the Hip, no differences were observed between PERM
nd vehicle treated rats.
In this regard, it should be argued that the spatial working
emory necessary to complete a continuous foraging task (as
ur T-maze) is supported by integration of signals originated
rom multiple brain regions and encoding not only for allocentric
visuospatial signals existing in the external environment) repre-
entations of space, but also for egocentric (intrinsic representation
ased on the ownmovement patterns) stimuli (Oliveira et al., 1997;
omez et al., 2009). Hippocampal activity is important for a con-
guration of an allocentric map (Olvera-Cortés et al., 2002, 2004;
oucet, 1993) that can then be translated into effective working
emory performance in the PFC (Dégenètais et al., 2003] by virtue
f the direct Hip-PFC connections (Cenquizca and Swanson, 2007).
hereas, for egocentric processing, connectivity between the Str
nd themPFC appears to play a primary role (McDonald andWhite,
994; Postle and D’Esposito, 2003). Hence, our ﬁndings showing
selective effect of PERM treatment on the T-maze task point to
n involvement of frontal cortico-striatal circuitry rather than to
role for the Hip. To explore this hypothesis at neurochemical
evel, we measured the concentration of DA, NE, 5-HT and their
etabolites in the PFC, Str and Hip. The most striking ﬁnding was
n the Str where DA levels were decreased of about 10 times in
ERM treated rats. A less pronounced reduction (two times) in DA
oncentration was also observed in the Hip. In these areas, a com-
ensatory increase of DA turnover (DOPAC/DA and HVA/DA) was
lso observed. These results led us to speculate that DA depletion
n Str and to some extent in the Hip could be responsible for the
isruption of temporal perception (i.e., slowing the clock-speed)
hich could explain the reduction in the CRT following PERM treat-ment. In the T-maze task, our animals appeared more hesitant in
choosing whether to go left or right to obtain the reward. This
behavior has some similarities with that of patients with Parkin-
son’s disease who have difﬁculty in initiating motor commands
because of a lack of striatal DA resulting in an overactive indi-
rect pathway leading to excessive cortical inhibition (Filion and
Tremblay, 1991; Jellinger, 2002).
Contrary to DA, the NE level was increased in Hip (1.4 times),
Str (2.8 times) and mPFC (8 times) of PERM treated rats compared
to controls. As reported in previous studies, brain NE system acti-
vation may stimulate arousal and contribute to execution of goal
oriented actions (Frazer, 2000; Aston-Jones et al., 1991). On the
other hand, NE has an inverted U-shaped inﬂuence on these behav-
ioral outcomes (Birnbaum et al., 2004). Hence, it is possible that if
theNEsystem is excessively stimulated, as for example in themPFC,
it may mediate disruption of these behaviors. Finally, a signiﬁcant
reduction of 5-HT levels in the PFC of PERM treated rats was also
observed. These data are in line with a classical view of a functional
competition between NE and 5-HT in behavioral control (Ellison,
1979).
To further examine the possibility that these changes in cate-
cholamine transmission might have resulted in a hypometabolic
state of mPFC neurons, glucose and lactate concentrations in the
mPFC were measured. To support this possibility, results revealed
reduction in glucose consumption and lactate production hence
indicating a signiﬁcant impairment in energy metabolism in the
mPFC of PERM treated animals as compared to controls.
It should be noted, however, that the amount of PERM given to
animals led to higher urine concentration of its metabolite than
those previously reported in children. In fact, at the end of the
15-day dosing period, the urinary 3-PBA concentration in rats was
41.50g/L (0.11±0.01g in a mean urinary volume of 2.65mL),
whereas in children the median (as 50th percentile) value ranged
from 0.3g/L to 5.0g/L according to the different studies (Barr
et al., 2010; Naeher et al., 2010; Becker et al., 2006; Zartarian et al.,
2012). However, 3-PBA levels in children were also found as high
as 20g/L at the 95th percentile. Of note, the excretion curve of
rats and humans (90% of 3-PBA excreted within the ﬁrst 24h fol-
lowing exposure) remained identical (Kühn et al., 1999). Besides,
in our rats the 3-PBA was completely eliminated 96h after the last
treatment.
Taken together, the present ﬁndings indicate that neonatal
exposure (15 days) to 34mg/kg of PERMcould selectively alter cog-
nitive functions associatewithworkingmemory processing. To our
knowledge, at present it is unknown whether administration of
lower doses of pyretroids for longer periods could induce cognitive
dysfunctions similar to those observed in the presentwork. Further
studies are warranted to explore this possibility.
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